Human neutralizing monoclonal antibodies to respiratory syncytial virus
US5762905A · kind A · utility
55Cited by
4References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 10, 1993 |
| Grant date | Jun 9, 1998 |
| Priority date | — |
| Expiry date | Dec 10, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Human monoclonal antibodies and fragments thereof which bind and neutralize respiratory syncytial virus (RSV) antigenic subgroups A and B are disclosed. Also disclosed are diagnostic and immunotherapeutic methods of using the monoclonal antibodies as well as cell lines producing the monoclonal antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.